Monoclonal microbial developer Evelo Biosciences has completed a $50m round featuring GV, Celgene and Mayo Clinic that followed a $35m series A in 2015.

Speech generation device developer Project Vive is the grand prize winner at the Cisco Global Problem Solver Challenge.

The precision medicine company, set up by molecular biology company Qiagen and science park BioBay, will use the money to transition towards a full-fledged products company.

Existing backer Kraft Group returned to take part in a $12.3m round that boosted the oncology diagnostics technology provider's total funding to more than $53m.

Topical skin treatment developer and JLabs graduate Sienna Biopharmaceuticals has filed for a $74.8m initial public offering, after raising $86m in venture funding.

MobileODT has now raised more than $13m altogether, after closing a series B round in which Tristel paid $750,000 for a stake of almost 3.3%.

Novartis has joined Shinsei Corporate Investment, Seventure Partners, INCJ and Mitsubishi UFJ Capital in a $13.2m round for the cancer drug developer.

Axonics Modulation Technologies has added more than $20m to a Legend Capital-backed series C round that took the company's total funding past the $100m mark.

The obstetrics care platform developer has received new funding in a round featuring Chemo Group and corporate venturing unit Aurora Health Care Ventures.